|
ARL8A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.356100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.084000E-02 |
| Normal-vs-Stage2 |
6.400200E-01 |
| Normal-vs-Stage3 |
3.459600E-03 |
| Normal-vs-Stage4 |
1.716780E-03 |
| Stage1-vs-Stage2 |
1.952010E-01 |
| Stage1-vs-Stage3 |
1.948010E-01 |
| Stage1-vs-Stage4 |
3.002200E-02 |
| Stage2-vs-Stage3 |
5.122200E-02 |
| Stage2-vs-Stage4 |
1.429680E-02 |
| Stage3-vs-Stage4 |
3.122200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.439200E-03 |
| Normal-vs-AfricanAmerican |
3.72360000000516E-05 |
| Normal-vs-Asian |
1.661970E-01 |
| Caucasian-vs-AfricanAmerican |
1.83514999999579E-05 |
| Caucasian-vs-Asian |
3.949200E-01 |
| AfricanAmerican-vs-Asian |
3.844400E-04 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.943400E-03 |
| Normal-vs-Female |
9.643900E-03 |
| Male-vs-Female |
3.955400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.736200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.475570E-02 |
| Normal-vs-Age(61-80Yrs) |
1.256180E-02 |
| Normal-vs-Age(81-100Yrs) |
1.041620E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.676200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.281400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.626600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.312800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.308800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.241600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.757800E-01 |
| Classical-VS-Follicular |
8.636600E-03 |
| Classical-VS-Other |
9.586000E-01 |
| Classical-VS-Normal |
6.751400E-04 |
| Tall-VS-Follicular |
1.323450E-01 |
| Tall-VS-Other |
9.478600E-01 |
| Tall-VS-Normal |
2.708000E-02 |
| Follicular-VS-Other |
4.408800E-01 |
| Follicular-VS-Normal |
5.329000E-01 |
| Other-VS-Normal |
1.722770E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.561980E-01 |
| Normal-vs-N1 |
1.283370E-01 |
| N0-vs-N1 |
4.912600E-01 |
|
|
